Kangmei Pharmaceutical Co Ltd - Company Profile

Powered by

All the data and insights you need on Kangmei Pharmaceutical Co Ltd in one report.

$395 $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Kangmei Pharmaceutical Co Ltd Strategy Report

  • Understand Kangmei Pharmaceutical Co Ltd position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Kangmei Pharmaceutical Co Ltd: Overview

Select Item

Kangmei Pharmaceutical Co Ltd (Kangmei) is a manufacturer and distributor of herbal medicine. The company provides herbal raw materials and preparations. Its products include Chinese herbal medicine, bottled single product and chemical drugs, among others. Kangmei provides chemical drugs such as clarithromycin dispersible tablets, doxazosin mesylate tablets, propiverine hydrochloride tablets, and paracetamol and pseudoephedrine hydrochloride tablets. The company also offers Xinkaihe warm tea, Ginkgo thirty-seven hawthorn polyphenol capsules, Propolis, McKinley card Calcium Iron zinc and selenium chewable tablets and Happiness red Luzhou nourishing Okuma. Kangmei is headquartered in Shenzhen, Guangdong, China.

 Gain a 360-degree view of Kangmei Pharmaceutical Co Ltd and make more informed decisions for your business Gain a 360-degree view of Kangmei Pharmaceutical Co Ltd and make more informed decisions for your business Find out more
Headquarters China
Address Taike Road, Xiameilin, Futian District, Shenzhen, Guangdong, 518000
Website www.kangmei.com.cn
Telephone 86 755 33187777
No of Employees 6,371
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange 600518 (SHA)
Revenue (2022) $621.3M 0.7% (2022 vs 2021)
EPS XYZ
Net Income (2022) XYZ -134% (2022 vs 2021)
Market Cap* $4.0B
Net Profit Margin (2022) XYZ -133.7% (2022 vs 2021)
* As of and is in US$
View Kangmei Pharmaceutical Co Ltd financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Kangmei Pharmaceutical Co Ltd premium industry data and analytics

15+

Marketed Drugs

Understand Kangmei Pharmaceutical Co Ltd’s commercialized product portfolio to stay one step ahead of the market.

2

Clinical Trials

Determine Kangmei Pharmaceutical Co Ltd go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

1

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Kangmei Pharmaceutical Co Ltd’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products
Chinese Herbal Medicine
Bottled Single Product
Participation Xinkaihe
XYZ
XYZ
XYZ
Understand Kangmei Pharmaceutical Co Ltd portfolio and identify potential areas for collaboration Understand Kangmei Pharmaceutical Co Ltd portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2023 Contracts/Agreements In October, the company signed a cooperation agreement with Kangmei Pharmaceutical to make changes in close linkage and efficient docking.
2023 Contracts/Agreements In March, the company entered into a partnership with PSM Puning City to conduct free clinics and drug safety science popularization activities.
2022 Contracts/Agreements In June, the company entered into an agreement with Dingxi Municipal People’s Government to improve the influence of the National Traditional Chinese Medicine Expo platform.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters Kangmei Pharmaceutical Co Ltd China National Accord Medicines Corporation Ltd Tasly Pharmaceutical Group Co Ltd Zhejiang Conba Pharmaceutical Co Ltd Jiangsu Nhwa Pharmaceutical Co Ltd
Headquarters China China China China China
City Shenzhen Shenzhen Tianjin Hangzhou Xuzhou
State/Province Guangdong Guangdong Tianjin Zhejiang Jiangsu
No. of Employees 6,371 39,296 9,183 8,415 4,955
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Lai Zhijian Chairman Executive Board 2022 54
Liu Guowei Managing Director Executive Board 2020 50
Gong Guibo Deputy General Manager; Chief Financial Officer Senior Management 2020 49
Liu Xinquan Deputy General Manager Senior Management 2022 49
He Zezheng Deputy General Manager Senior Management 2021 46
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Kangmei Pharmaceutical Co Ltd key executives to enhance your sales strategy Gain insight into Kangmei Pharmaceutical Co Ltd key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward